pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. The earlier HTAs, researchers and pharma companies can start that engagement the better.

Drugs 99

Drugs Pharma Companies Licensing Licensing 99

Pharmaceutical Technology

JULY 15, 2022

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328

Insulin Manufacturing Contract Manufacturing Production 328

pharmaphorum

MAY 21, 2021

Based in Cambridge, Arecor has proprietary formulation technology and plans to enter development partnerships and licence out drugs to big pharma companies, looking for milestone payments and royalties as they progress through the development process and on commercialisation.

Insulin 52

Insulin Drugs Production Marketing 52

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. This will also mean the industry needs to think about how HCPs will want to interact with pharma companies. “If

Pharma Companies 111

Pharma Companies Insulin Packaging Packaging 111

XTalks

MAY 13, 2021

Novo Nordisk’s oral GLP-1 diabetes drug Rybelsus (semaglutide) has been up in the ranks this year in pharma TV ad spending, with the Danish pharma company having spent $19.9 The drug is a human glucagon-like peptide-1 (GLP-1) agonist that functions to increase insulin secretion from the pancreas. million and $18.6

Insulin 104

Insulin Marketing Drugs Branding 104

Pharmaceutical Technology

JANUARY 31, 2023

While insulin price caps will begin this year, larger effects will be delayed until 2026 – when the US federal government will be allowed to negotiate Medicare prices and demand rebates from drug companies that price gouge. That leaves three years for pharma companies to prepare.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

pharmaphorum

NOVEMBER 22, 2022

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and patients who utilise it to engage with their medical communities. The post Elon Musk, pharma, and the future of Twitter appeared first on.

Branding 59

Branding Pharma Companies Marketing Insulin 59

pharmaphorum

JULY 13, 2022

And while pharma companies are working hard to find treatments for these diseases, they have a major problem that must be addressed before that work can be done effectively: the lack of objective, quantitative measurement tools for assessing the progression – or even the presence or absence – of these conditions.

Trials 98

Trials Clinical Trials Clinical Trials Pharma Companies 98

XTalks

FEBRUARY 21, 2024

Similar to tirzepatide, dulaglutide stimulates insulin secretion, inhibits glucagon release and promotes satiety. These candidate drugs are a small sample from a diverse array of GLP-1 receptor agonists that are being tested by pharma companies in varying formulations, dosing regimens and clinical profiles.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

XTalks

JANUARY 5, 2024

Related: Zepbound, Obesity Version of Eli Lilly’s Mounjaro, Finally Gets FDA Nod So far, LillyDirect provides support for 14 Lilly medicines, with 12 being different formulations and types of insulin. In addition to these and Zepbound, Lilly’s medication for migraine management, Emgality (galcanezumab), is also available through the website.

Drugs 59

Drugs Pharmacy Cosmetics Medicine 59

The Pharma Data

MAY 14, 2021

First, most are on the payroll of the big pharma companies earning lucrative commissions for pushing their drugs…. Yes, it’s important to get rid of unproductive carbohydrates, refined sugars and processed foods… …If you don’t you’ll suffer more insulin resistance and unstable blood readings.

Doctor 52

Doctor Doctors Insulin Production 52

pharmaphorum

JUNE 2, 2022

Evaluate expects five big pharma companies to be reliant on orphan drugs to provide 20% or more of their sales by 2026, with Johnson & Johnson topping the list at an estimated 39% of all sales. This can be seen with the debate in the US over the price of insulin , with the cost of drugs becoming a wider political issue in the US.

Drugs 52

Drugs Sales Marketing Development 52

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): This is really interesting too and that is the one that we’ve spoken about earlier in previous conversations was the aerosolized insulin? Robin (Guest): Eliminating the needle and it’s a smart connected device and so you can track the insulin uses really really easily. Robin (Guest): Yup. Don ( PMN): Wow.

Insulin 52

Insulin Marketing Doctors Doctor 52

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): This is really interesting too and that is the one that we’ve spoken about earlier in previous conversations was the aerosolized insulin? Robin (Guest): Eliminating the needle and it’s a smart connected device and so you can track the insulin uses really really easily. Robin (Guest): Yup. Don ( PMN): Wow.

Insulin 52

Insulin Doctors Doctor Marketing 52

XTalks

AUGUST 17, 2020

Cue Biopharma has an autoimmune disease collaboration with Merck, from which early data from a type 1 diabetes program was released earlier this year by the pharma company.

Protein 98

Protein Engineer Immune Response In-Vivo 98

Delveinsight

AUGUST 25, 2021

LANTUS (Insulin glargine) injection used to treat type 1 and 2 diabetes mellitus is another Sanofi product that is not far behind Dupixent. The Healthcare market comprises several pharmaceutical and biotech companies; some are established goliaths while many more continue to emerge. It generated a revenue share of 9.8% (USD 4.2

Vaccine 98

Vaccine Vaccination Drugs Sales 98

pharmaphorum

JUNE 10, 2021

The fundamental misconception among the public, the media and even some lawmakers is that higher drug list prices are the result of drug manufacturers being in a monopolistic position to endlessly raise prices on critical drugs like insulin and then rake in big profits. What’s Next: How Should Pharma Companies Respond?

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

XTalks

AUGUST 25, 2023

After seeking approval in May to settle litigations over pricing of its insulin product Humalog, Eli Lilly is facing resistance from nine US states who are asking a New Jersey federal court to delay approval of the proposed $13.5 US insulin makers have come under fire as the US is the country with the most expensive insulin in the world.

Insulin 52

Insulin Production Pharma Companies Life Science 52

pharmaphorum

SEPTEMBER 1, 2020

The period between 1918 and 1939 was marked by two breakthroughs that presaged the arrival of the pharma industry as we know it today. The first was insulin – Frederick Banting and colleagues managed to isolate insulin that could treat diabetes, up until that point a fatal condition.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two

Insulin 96

Insulin Pharmacy Pharma Companies Drugs 96

XTalks

JUNE 14, 2024

The province takes pride in being home to the discovery of insulin and stem cells, and the largest life sciences jurisdiction in Canada.

Life Science 52

Life Science Insulin Research Manufacturing 52

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. Jonathan was in his late 40s and came into my pharmacy to pick up his insulin for his diabetes, when he told me about his father. It’s all about the bottom line, at any cost.

Production 52

Production Pharmacy Doctors Doctor 52

World of DTC Marketing

DECEMBER 7, 2021

LEAD IN: Pharma companies are a business and have the right to make money but at what cost and how much is enough? There is no debate that today’s pharmaceutical companies have helped us lead longer and better lives, but they have made their shareholders and CEOs a lot of money in the process. Is this acceptable?

Vaccination 222

Vaccination Vaccine Insulin Pharma Companies 222

XTalks

SEPTEMBER 11, 2023

billion Insulin Aspart Maker: Novo Nordisk Treatment for: Diabetes Medicare Spend: $2.6 Astellas Pharma was also part of the litigating pharma companies but withdrew its lawsuit last Thursday, as it managed to evade CMS’ initial negotiation list. billion Medicare enrollees who used drug: 3.7

Drugs 108

Drugs Sales Insulin Life Science 108

XTalks

DECEMBER 3, 2024

From blockbuster drugs like Ozempic to foundational treatments like insulin, these therapies showcase the diverse strategies used by pharma companies to meet the needs of a rapidly growing market. The company is targeting revenue of $40.4 Price of Insulin: Varies significantly by type and brand of insulin.

Sales 105

Sales Insulin FDA Approval Drugs 105

pharmaphorum

NOVEMBER 4, 2021

Other elements of the plans include tax penalties if pharma companies hike their prices faster than inflation, setting a cap of $35 per month out-of-pocket for insulin, and making sure that Medicare Part D patients don’t pay more than $2,000 per year for medications bought at the pharmacy.

Drugs 52

Drugs Insulin Medicine Marketing 52

World of DTC Marketing

JUNE 16, 2021

The pharma industry has been riding a wave of public approval since they developed a vaccine to fight COVID-19, but that goodwill is going to be short lived thanks, in part, to the $56,000 price tag of Biogen’s new drug and insulin that too many people still can’t afford.

Drugs 180

Drugs Branding Medicine Insulin 180

World of DTC Marketing

DECEMBER 16, 2021

(Axios) Second-quarter results are still pouring in, but so far, a vast majority of health care companies are reporting profits that many people assumed would not have been possible as the pandemic continued. Drug sales fell across many pharma companies but cutting administrative and research costs kept earnings at industry highs.

Insulin 205

Insulin Pharma Companies Drugs Branding 205

World of DTC Marketing

DECEMBER 14, 2021

WHAT’S HAPPENING: In the Build Back Better bill , Democrats are actually proposing limiting insulin prices to $35 a month but Republicans can’t have any of that. PhRMA spent pharma’s money well and bought some politicians while people who need insulin are suffering.

Insulin 184

Insulin Branding Drugs Production 184

XTalks

FEBRUARY 14, 2024

US drug pricing has been under fire for many years and things took a significant turn last year when the three major insulin makers (Eli Lilly, Sanofi and Novo Nordisk) decided to slash the price of their insulin products and agreed to cap out-of-pocket costs at $35 per month for patients with insurance coverage.

Drugs 52

Drugs Insulin Pharmacy Development 52

Pharmacy Checkers

JULY 28, 2020

2) Allow for the re-importation of insulin. The part of the executive order specific to insulin could be a game changer more immediately. The executive order seems to state that the price of insulin is an emergency, and that’s unambiguously true. 3) Finish the federal rule on importation of drugs from Canada.

Drugs 68

Drugs Insulin Pharmacy Licensing 68